Russell Investments Group Ltd. grew its holdings in shares of Balchem Co. (NASDAQ:BCPC – Get Rating) by 6.7% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 22,198 shares of the basic materials company’s stock after purchasing an additional 1,391 shares during the quarter. Russell Investments Group Ltd. owned about 0.07% of Balchem worth $3,034,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in BCPC. Stephens Investment Management Group LLC lifted its holdings in shares of Balchem by 1.4% in the first quarter. Stephens Investment Management Group LLC now owns 320,085 shares of the basic materials company’s stock worth $43,756,000 after buying an additional 4,457 shares in the last quarter. Victory Capital Management Inc. lifted its holdings in shares of Balchem by 84.2% in the first quarter. Victory Capital Management Inc. now owns 6,772 shares of the basic materials company’s stock worth $834,000 after buying an additional 3,095 shares in the last quarter. Martin & Co. Inc. TN lifted its holdings in shares of Balchem by 2.0% in the first quarter. Martin & Co. Inc. TN now owns 18,386 shares of the basic materials company’s stock worth $2,513,000 after buying an additional 360 shares in the last quarter. Mutual of America Capital Management LLC lifted its holdings in shares of Balchem by 5.5% in the first quarter. Mutual of America Capital Management LLC now owns 4,666 shares of the basic materials company’s stock worth $638,000 after buying an additional 242 shares in the last quarter. Finally, Nisa Investment Advisors LLC purchased a new stake in shares of Balchem in the first quarter worth about $784,000. Institutional investors own 89.60% of the company’s stock.
Wall Street Analyst Weigh In
BCPC has been the topic of a number of recent analyst reports. StockNews.com downgraded shares of Balchem from a “buy” rating to a “hold” rating in a research note on Monday, August 1st. HC Wainwright lowered their target price on shares of Balchem from $155.00 to $152.00 and set a “buy” rating on the stock in a research note on Monday, May 2nd.
Insiders Place Their Bets
In other Balchem news, VP Gunsteren Job Leonard Van sold 3,601 shares of Balchem stock in a transaction that occurred on Wednesday, August 3rd. The shares were sold at an average price of $125.62, for a total transaction of $452,357.62. Following the transaction, the vice president now directly owns 1,430 shares of the company’s stock, valued at $179,636.60. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 1.60% of the company’s stock.
Balchem Trading Up 3.6 %
Shares of BCPC opened at $134.17 on Friday. The firm’s 50 day simple moving average is $126.63 and its 200 day simple moving average is $130.59. The company has a market capitalization of $4.31 billion, a P/E ratio of 40.17 and a beta of 0.59. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.62 and a quick ratio of 1.64. Balchem Co. has a 1-year low of $110.15 and a 1-year high of $174.29.
Balchem Profile
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products.
Read More
Want to see what other hedge funds are holding BCPC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Balchem Co. (NASDAQ:BCPC – Get Rating).
Receive News & Ratings for Balchem Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Balchem and related companies with MarketBeat.com’s FREE daily email newsletter.
